Adipose tissue-resident macrophages and obesity

  • Allah Nawaz University of Toyama, 2630 Sugitani,Toyama 930-0194, Japan
  • Tomonobu Kado University of Toyama, 2630 Sugitani,Toyama 930-0194, Japan
  • Yoshiko Igarashi University of Toyama, 2630 Sugitani,Toyama 930-0194, Japan
  • Yagi Kunimasa University of Toyama, 2630 Sugitani,Toyama 930-0194, Japan
  • Isao Usui University of Toyama, 2630 Sugitani,Toyama 930-0194, Japan
  • Shiho Fujisaka University of Toyama, 2630 Sugitani,Toyama 930-0194, Japan
  • Kazuyuki Tobe University of Toyama, 2630 Sugitani,Toyama 930-0194, Japan

Abstract

Type 2 diabetes and insulin resistance are one of the major consequences of obesity as a result of inflammation in adipose tissues. Adipose tissue-resident macrophages (ATMs) have a primary role in tissue remodeling and maintenance of homeostasis within adipose tissue. Two different types of macrophages are present in adipose tissue i.e. M1 and M2-type. Obesity is associated phenotypic transformation of macrophages, from anti-inflammatory M2 to pro-inflammatory M1 macrophages. M1-type macrophages increases in obesity and contribute to the development of type 2 diabetes and insulin resistacne. In contrast, M2 ATMs secretes anti-inflammatory cytokines and are involved in maintaining insulin sensitivity. However, little is known about the role of M2 macrophages in adipose tissue. Literature related to the role of M1 and M2 macrophages in metabolism have been reviewed in this article with emphasis on the macrophages associated with adipose tissues. Role of M2 macrophages in adipose tissues have also been highlighted in this article to enhance our knowledge and understanding of macrophages homogeneity.

Author Biographies

Allah Nawaz, University of Toyama, 2630 Sugitani,Toyama 930-0194, Japan

First Department of Internal Medicine

Tomonobu Kado, University of Toyama, 2630 Sugitani,Toyama 930-0194, Japan

First Department of Internal Medicine, 

Yoshiko Igarashi, University of Toyama, 2630 Sugitani,Toyama 930-0194, Japan

First Department of Internal Medicine, 

Yagi Kunimasa, University of Toyama, 2630 Sugitani,Toyama 930-0194, Japan

First Department of Internal Medicine

Isao Usui, University of Toyama, 2630 Sugitani,Toyama 930-0194, Japan

First Department of Internal Medicine

Shiho Fujisaka, University of Toyama, 2630 Sugitani,Toyama 930-0194, Japan

First Department of Internal Medicine

Kazuyuki Tobe, University of Toyama, 2630 Sugitani,Toyama 930-0194, Japan

First Department of Internal Medicine

Published
2017-11-01
Issue
Vol 5 No 3 (2017): Contents of Volume 5(3) July-September 2017
Section
Articles

Copyright (c) 2017 RADS Journal of Pharmacy and Pharmaceutical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License

Submitting a manuscript to a journal implies that the work has not previously been published in any other journal, printed or online (save as an abstract or an academic thesis), and that it is not currently being considered for publication elsewhere.